{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:29:28Z","timestamp":1762176568108},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T00:00:00Z","timestamp":1332979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033200","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T17:21:30Z","timestamp":1333041690000},"page":"e33200","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients"],"prefix":"10.1371","volume":"7","author":[{"given":"Wenting","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiucun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daru","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P","article-title":"Estimates of the worldwide incidence of 25 major cancers in 1990.","volume":"80","author":"DM Parkin","year":"1999","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2008.17.2056","article-title":"First-line chemotherapy for non-small-cell lung cancer: Is there a superior regimen based on histology?","volume":"26","author":"LH Einhorn","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics, 2002.","volume":"52","author":"A Jemal","year":"2002","journal-title":"Ca-Cancer J Clin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1378\/chest.122.3.1037","article-title":"Prognostic factors in non-small cell lung cancer - A decade of progress.","volume":"122","author":"MD Brundage","year":"2002","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects.","volume":"348","author":"WE Evans","year":"2003","journal-title":"New Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance.","volume":"22","author":"ZH Siddik","year":"2003","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1349-7006.2007.00557.x","article-title":"Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy.","volume":"98","author":"K Azuma","year":"2007","journal-title":"Cancer Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.","volume":"22","author":"S Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref9","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.","volume":"8","author":"RVN Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.embor.7400418","article-title":"Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells.","volume":"6","author":"Q Wu","year":"2005","journal-title":"Embo Reports"},{"key":"ref11","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.","volume":"61","author":"MR Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency.","volume":"21","author":"RM Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression.","volume":"17","author":"KJ Wolfe","year":"2007","journal-title":"Pharmacogenet Genom"},{"key":"ref14","first-page":"77","article-title":"Polymorphisms in the DNA repair gene XPD: Correlations with risk and age at onset of basal cell carcinoma.","volume":"8","author":"M Dybdahl","year":"1999","journal-title":"Cancer Epidem Biomar"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/carcin\/bgg115","article-title":"Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.","volume":"24","author":"WM Gao","year":"2003","journal-title":"Carcinogenesis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2008.20.8793","article-title":"Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics.","volume":"27","author":"DR Gandara","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref17","first-page":"8654","article-title":"A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.","volume":"61","author":"DJ Park","year":"2001","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1158\/1078-0432.CCR-08-2715","article-title":"Association of XPD Polymorphisms with Severe Toxicity in Non-Small Cell Lung Cancer Patients in a Chinese Population.","volume":"15","author":"WT Wu","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and Response Criteria of the Eastern-Cooperative-Oncology-Group.","volume":"5","author":"MM Oken","year":"1982","journal-title":"Am J Clin Oncol-Canc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/519024","article-title":"A Bayesian measure of the probability of false discovery in genetic epidemiology studies.","volume":"81","author":"J Wakefield","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/carcin\/22.4.593","article-title":"Genetic polymorphisms in DNA repair genes and risk of lung cancer.","volume":"22","author":"D Butkiewicz","year":"2001","journal-title":"Carcinogenesis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/annonc\/mdj135","article-title":"Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients.","volume":"17","author":"R de las Penas","year":"2006","journal-title":"Annals of Oncology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","article-title":"Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.","volume":"15","author":"D Isla","year":"2004","journal-title":"Annals of Oncology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.dnarep.2007.02.010","article-title":"Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription.","volume":"6","author":"JP Laine","year":"2007","journal-title":"DNA Repair"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/1477-3163.54918","article-title":"Conformational effects of a common codon 751 polymorphism on the C-terminal domain of the xeroderma pigmentosum D protein.","volume":"8","author":"R Monaco","year":"2009","journal-title":"J Carcinog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","article-title":"Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.","volume":"44","author":"JS Ryu","year":"2004","journal-title":"Lung Cancer"},{"key":"ref27","first-page":"859","article-title":"Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.","volume":"10","author":"CY Yao","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref28","first-page":"7430","article-title":"Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp\/Asp genotype.","volume":"61","author":"H Seker","year":"2001","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1200\/JCO.2008.18.0406","article-title":"Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non-Small-Cell Lung Cancer.","volume":"26","author":"RS Heist","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.lungcan.2010.10.011","article-title":"No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis.","volume":"72","author":"M Yin","year":"2011","journal-title":"Lung Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.11136","article-title":"Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population.","volume":"105","author":"G Liang","year":"2003","journal-title":"Int J Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archotol.128.9.1084","article-title":"DNA repair gene ERCC1 and ERCC2\/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.","volume":"128","author":"EM Sturgis","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref33","first-page":"5612","article-title":"A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.","volume":"60","author":"SL Winsey","year":"2000","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2009.60","article-title":"A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.","volume":"22","author":"BZ Ring","year":"2009","journal-title":"Modern Pathol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.leu.2404172","article-title":"Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.","volume":"20","author":"W Chng","year":"2006","journal-title":"Leukemia"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T10:00:04Z","timestamp":1540288804000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033200"}},"subtitle":[],"editor":[{"given":"Alfons","family":"Navarro","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033200","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}